Pluri Inc. (PLUR.TA)
PLUR.TA Stock Price Chart
Explore Pluri Inc. interactive price chart. Choose custom timeframes to analyze PLUR.TA price movements and trends.
PLUR.TA Company Profile
Discover essential business fundamentals and corporate details for Pluri Inc. (PLUR.TA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Oct 2011
Employees
106.00
Website
https://www.pluri-biotech.comCEO
Yaacov Yanay
Description
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the muscle recovery following surgery for hip fracture; and Phase I/II clinical trial for the treatment of steroid-refractory graft versus host disease in collaboration with Tel Aviv Sourasky Medical Center, as well as completed a Phase II clinical trial for the treatment of acute respiratory distress syndrome associated with COVID-19 and a Phase I clinical trial for incomplete recovery following bone marrow transplantation. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation; and a solution for the treatment of acute radiation syndrome through its collaboration in the United States with the National Institutes of Health and the U.S. Department of Defense. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
PLUR.TA Financial Timeline
Browse a chronological timeline of Pluri Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 25 Jun 2025
Earnings released on 13 May 2025
EPS came in at -ILA 3.50 , while revenue for the quarter reached ILA 1.60M , beating expectations by +299.37%.
Earnings released on 11 Feb 2025
EPS came in at -ILA 1.94 , while revenue for the quarter reached ILA 672.55K .
Earnings released on 12 Nov 2024
EPS came in at -ILA 4.07 , while revenue for the quarter reached ILA 1.23M .
Earnings released on 25 Jun 2024
EPS came in at -ILA 4.01 , while revenue for the quarter reached ILA 361.54K .
Earnings released on 10 May 2024
EPS came in at -ILA 3.74 falling short of the estimated -ILA 0.89 by -321.28%, while revenue for the quarter reached ILA 261.80K , missing expectations by -99.38%.
Stock split effective on 1 Apr 2024
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Feb 2024
EPS came in at -ILA 3.40 , while revenue for the quarter reached ILA 377.99K .
Earnings released on 14 Nov 2023
EPS came in at -ILA 3.68 , while revenue for the quarter reached ILA 206.83K .
Earnings released on 30 Jun 2023
EPS came in at -ILA 4.97 , while revenue for the quarter reached ILA 408.59K .
Earnings released on 10 May 2023
EPS came in at -ILA 5.47 surpassing the estimated -ILA 8.65 by +36.82%, while revenue for the quarter reached ILA 311.43K .
Earnings released on 31 Dec 2022
EPS came in at -ILA 6.74 surpassing the estimated -ILA 9.01 by +25.15%, while revenue for the quarter reached ILA 6.89K .
Earnings released on 21 Sept 2022
EPS came in at -ILA 0.28 surpassing the estimated -ILA 0.35 by +20.00%, while revenue for the quarter reached ILA 307.74K .
Earnings released on 30 Jun 2022
EPS came in at -ILA 7.78 .
Earnings released on 9 May 2022
EPS came in at -ILA 0.31 surpassing the estimated -ILA 0.36 by +13.89%, while revenue for the quarter reached ILA 747.08K .
Earnings released on 7 Feb 2022
EPS came in at -ILA 0.34 surpassing the estimated -ILA 0.38 by +10.53%.
Earnings released on 8 Nov 2021
EPS came in at -ILA 0.36 surpassing the estimated -ILA 0.41 by +12.20%.
Earnings released on 30 Jun 2021
EPS came in at -ILA 12.01 .
Earnings released on 6 May 2021
EPS came in at -ILA 0.48 falling short of the estimated -ILA 0.33 by -45.45%.
Earnings released on 8 Feb 2021
EPS came in at -ILA 0.49 falling short of the estimated -ILA 0.26 by -88.46%.
Earnings released on 5 Nov 2020
EPS came in at -ILA 0.33 falling short of the estimated -ILA 0.10 by -230.00%.
PLUR.TA Stock Performance
Access detailed PLUR.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.